B BRAUN P5941 PRE-MIXED PHARMACEUTICALS 4 mg/mL: 0.4% Lidocaine Hydrochloride & 5% Dextrose Injection (2g), 500mL, EXCEL® Container, 24/cs
B BRAUN P5941 PRE-MIXED PHARMACEUTICALS 4 mg/mL: 0.4% Lidocaine Hydrochloride & 5% Dextrose Injection (2g), 500mL, EXCEL® Container, 24/cs
• Model: P5941
• Strength: 4 mg/mL (0.4%) Lidocaine Hydrochloride in 5% Dextrose Injection USP (2 g total lidocaine per 500 mL)
• Volume: 500 mL per bag
• Case of 24
The B. Braun P5941 injection provides a ready‑to‑use, premixed formulation of lidocaine hydrochloride (4 mg/mL) in a 5% dextrose carrier, supplied in a 500 mL EXCEL® container. This preparation is designed for intravenous administration where lidocaine is indicated as an antiarrhythmic agent, offering the convenience of a pre‑mixed solution to reduce compounding errors and support efficient workflow in hospital or infusion‑center pharmacy settings. With a total of 2 g of lidocaine per 500 mL bag, the solution allows for streamlined dosing and infusion planning.
Material safety is a key feature: the container and solution are formulated without natural rubber latex, PVC, or DEHP, addressing concerns related to latex allergies and phthalate exposure. The EXCEL® flexible bag format provides a lighter‑weight, space‑efficient option compared to rigid containers, facilitating handling, storage, and disposal. The specific gravity of 1.018 indicates the density of the solution, which is relevant for infusion pump calibration and fluid compatibility checks.
Operationally, the P5941 solution supports facilities seeking to simplify medication preparation and improve safety by reducing in‑the‑field compounding. The 24‑bag case size balances inventory needs with storage constraints. Because it’s premixed, there is less risk of mixing errors or contamination during preparation, and the flexible bag format aids in rapid set‑up. In summary, this B. Braun premixed lidocaine/dextrose solution offers a reliable, safety‑oriented antiarrhythmic infusion option, optimized for modern hospital workflows.
Expertly formulated by B Braun, this pre-mixed pharmaceutical solution contains 4 mg/mL of lidocaine hydrochloride and 5% dextrose, providing efficient pain relief and glucose supply for patients in need. Packaged in a convenient 500mL EXCEL® container, this product comes in a 24/cs quantity, making it a reliable solution for medical professionals.
B BRAUN P5941 PRE-MIXED PHARMACEUTICALS 4 mg/mL: 0.4% Lidocaine Hydrochloride & 5% Dextrose Injection (2g), 500mL, EXCEL® Container, 24/cs
• Model: P5941
• Strength: 4 mg/mL (0.4%) Lidocaine Hydrochloride in 5% Dextrose Injection USP (2 g total lidocaine per 500 mL)
• Volume: 500 mL per bag
• Case of 24
The B. Braun P5941 injection provides a ready‑to‑use, premixed formulation of lidocaine hydrochloride (4 mg/mL) in a 5% dextrose carrier, supplied in a 500 mL EXCEL® container. This preparation is designed for intravenous administration where lidocaine is indicated as an antiarrhythmic agent, offering the convenience of a pre‑mixed solution to reduce compounding errors and support efficient workflow in hospital or infusion‑center pharmacy settings. With a total of 2 g of lidocaine per 500 mL bag, the solution allows for streamlined dosing and infusion planning.
Material safety is a key feature: the container and solution are formulated without natural rubber latex, PVC, or DEHP, addressing concerns related to latex allergies and phthalate exposure. The EXCEL® flexible bag format provides a lighter‑weight, space‑efficient option compared to rigid containers, facilitating handling, storage, and disposal. The specific gravity of 1.018 indicates the density of the solution, which is relevant for infusion pump calibration and fluid compatibility checks.
Operationally, the P5941 solution supports facilities seeking to simplify medication preparation and improve safety by reducing in‑the‑field compounding. The 24‑bag case size balances inventory needs with storage constraints. Because it’s premixed, there is less risk of mixing errors or contamination during preparation, and the flexible bag format aids in rapid set‑up. In summary, this B. Braun premixed lidocaine/dextrose solution offers a reliable, safety‑oriented antiarrhythmic infusion option, optimized for modern hospital workflows.
Expertly formulated by B Braun, this pre-mixed pharmaceutical solution contains 4 mg/mL of lidocaine hydrochloride and 5% dextrose, providing efficient pain relief and glucose supply for patients in need. Packaged in a convenient 500mL EXCEL® container, this product comes in a 24/cs quantity, making it a reliable solution for medical professionals.
Description
B BRAUN P5941 PRE-MIXED PHARMACEUTICALS 4 mg/mL: 0.4% Lidocaine Hydrochloride & 5% Dextrose Injection (2g), 500mL, EXCEL® Container, 24/cs
• Model: P5941
• Strength: 4 mg/mL (0.4%) Lidocaine Hydrochloride in 5% Dextrose Injection USP (2 g total lidocaine per 500 mL)
• Volume: 500 mL per bag
• Case of 24
The B. Braun P5941 injection provides a ready‑to‑use, premixed formulation of lidocaine hydrochloride (4 mg/mL) in a 5% dextrose carrier, supplied in a 500 mL EXCEL® container. This preparation is designed for intravenous administration where lidocaine is indicated as an antiarrhythmic agent, offering the convenience of a pre‑mixed solution to reduce compounding errors and support efficient workflow in hospital or infusion‑center pharmacy settings. With a total of 2 g of lidocaine per 500 mL bag, the solution allows for streamlined dosing and infusion planning.
Material safety is a key feature: the container and solution are formulated without natural rubber latex, PVC, or DEHP, addressing concerns related to latex allergies and phthalate exposure. The EXCEL® flexible bag format provides a lighter‑weight, space‑efficient option compared to rigid containers, facilitating handling, storage, and disposal. The specific gravity of 1.018 indicates the density of the solution, which is relevant for infusion pump calibration and fluid compatibility checks.
Operationally, the P5941 solution supports facilities seeking to simplify medication preparation and improve safety by reducing in‑the‑field compounding. The 24‑bag case size balances inventory needs with storage constraints. Because it’s premixed, there is less risk of mixing errors or contamination during preparation, and the flexible bag format aids in rapid set‑up. In summary, this B. Braun premixed lidocaine/dextrose solution offers a reliable, safety‑oriented antiarrhythmic infusion option, optimized for modern hospital workflows.
Expertly formulated by B Braun, this pre-mixed pharmaceutical solution contains 4 mg/mL of lidocaine hydrochloride and 5% dextrose, providing efficient pain relief and glucose supply for patients in need. Packaged in a convenient 500mL EXCEL® container, this product comes in a 24/cs quantity, making it a reliable solution for medical professionals.
